The following government grants in the FederalGrants.com database contain the term housing in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Analgesic, Anesthetic and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) (U01) Clinical Trials Not Allowed |
93.103 |
RFA-FD-21-026 |
| Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-021 |
| Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-035 |
| Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) |
93.351 |
PAR-21-167 |
| SmartTots (Strategies for Mitigating Anesthesia-Related neuroToxicity in Tots) Public-Private Partnership (PPP) under PASI (Pediatric Anesthesia Safety Initiative) (U01) Clinical Trials Not Allowed |
93.103 |
RFA-FD-21-25 |
| The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) |
93.398 |
PAR-21-128 |
| Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 - Independent Clinical Trial Not Allowed) |
93.113, 93.213, 93.242, 93.273, 93.279, 93.313, 93.398, 93.847, 93.865, 93.867 |
RFA-OD-21-005 |
| The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) |
93.398 |
PAR-21-111 |
| The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) |
93.398 |
PAR-21-318 |
| Enhancing Innovations in Advanced Manufacturing Technologies for Vaccines against Influenza and Emerging Infectious Diseases (R01) Clinical Trials Not Allowed |
93.103 |
RFA-FD-21-033 |
| AHRQ/PCORI Learning Health System Small Grant Pilot Program |
93.226 |
PA-21-202 |
| Department of the Interior - Bureau of Land Management Oregon/Washington Youth Conservation Opportunities on Public Lands |
15.243 |
L21AS00304 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) |
93.853 |
PAR-21-122 |
| Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
93.393, 93.399 |
PAR-21-190 |
| BRAIN Initiative: Secondary Analysis and Archiving of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-21-130 |
| Expanding the opioids system modeling efforts to more comprehensively address fentanyl, stimulants use, polysubstance use and associated outcomes.(U01) Clinical Trials Not Allowed |
93.103 |
RFA-FD-21-022 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) |
93.853 |
PAR-21-123 |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) |
93.213, 93.853 |
PAR-21-124 |
| GPD Capital Grant |
64.024 |
VA-GPD-CG-FY2021 |
| HEAL Initiative: Planning Studies for Initial Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (R34 Clinical Trial Not Allowed) |
93.121, 93.213, 93.242, 93.273, 93.846, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-21-016 |
| Migratory Bird Conservation in the Midwest |
15.647 |
F21AS00344 |
| Improving the Science Foundation for Bird Conservation |
15.637, 15.647 |
F21AS00358 |
| HEAL Initiative: Analgesic Development Initial Translational Efforts [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed) |
93.121, 93.213, 93.242, 93.273, 93.350, 93.846, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-21-015 |
| Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
PAR-21-163 |
| BRAIN Initiative: Integration and Analysis of BRAIN Initiative Data (R01 Clinical Trial Not Allowed) |
93.173, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-MH-21-135 |
| Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) |
93.077 |
RFA-OD-21-003 |
| Conservation Innovation Grants (CIG) for Federal fiscal year (FY) 2021 - ARKANSAS |
10.912 |
USDA-NRCS-AR-CIG-21-NOFO0001059 |
| Section 4 Capacity Building for Community Development and Affordable Housing |
14.252 |
FR-6400-N-07 |
| Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed) |
93.077 |
RFA-OD-21-004 |
| Department of the Interior - Bureau of Land Management (HQ) Wildlife Resource Management |
15.247 |
L21AS00357 |
| Announcement for Program Funding for NRCS' Conservation Innovation Grants (CIG) for Federal fiscal year (FY) 2021 - Wisconsin |
10.912 |
USDA-NRCS-WI-CIG-21-NOFO0001073 |
| National Resource Center on Nutrition and Aging |
93.045 |
HHS-2021-ACL-AOA-PPNU-0090 |
| Firearm Injury and Mortality Prevention Research (R21/R33 Clinical Trial Optional) |
93.213, 93.273, 93.279, 93.307, 93.313, 93.865, 93.866 |
PAR-21-191 |
| Conservation Innovation Grants (CIG) for Federal fiscal year (FY) 2021 - South Carolina |
10.912 |
USDA-NRCS-SC-CIG-21-NOFO0001084 |
| Tropical Medicine Research Centers (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-004 |
| New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional) |
93.839, 93.847, 93.866 |
PAS-21-150 |
| Department of the Interior - Bureau of Land Management (HQ) Fisheries and Aquatic Resource Management |
15.244 |
L21AS00356 |
| Firearm Injury and Mortality Prevention Research (R01Clinical Trial Optional) |
93.242, 93.273, 93.279, 93.307, 93.313, 93.865, 93.866 |
PAR-21-192 |
| NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed) |
93.262 |
PAR-21-193 |
| Tropical Medicine Research Centers Coordinating Center (U01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-005 |
Search Results 3401-3440 of 17607
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 [Next] |
